相关实验视频

Updated: Sep 12, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

对新型尼托芬醇-三混合分子的评估:生物查和计算分析

Sultan Onur¹, Mustafa Çeşme¹, Muhammet Köse¹

¹Department of Chemistry, Faculty of Sciences, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.

Future medicinal chemistry

|August 7, 2025

概括

新型尼托芬醇-三混合物显示出强大的胆酶抑制,抗氧化和抗癌活性. 化合物10e向乙胆酶 (AChE),而10a则表现出抗癌作用和抗氧化能力.

科学领域:

药用化学医学化学
有机合成有机合成
计算化学的计算化学

背景情况:

尼托醇和三醇支架被认为具有多种生物活动.
混合分子为开发新治疗剂提供了一个有前途的战略.
胆酶抑制是阿尔茨海默病治疗的关键目标.

研究的目的:

合成新的尼托芬醇 - 三醇混合分子.
评估它们的胆酶抑制,抗氧化和抗癌性质.
使用计算方法来描述它们的结合相互作用和药理动力学特征.

主要方法:

多步骤的有机合成和表征 (X射线衍射).
在体外测定胆酶抑制 (AChE,BuChE),抗氧化活性 (ABTS) 和细胞毒性 (Caco-2细胞).
在分析包括ADMET预测和分子对接.

主要成果:

成功合成了八种新的混合化合物.
化合物10e显示出强大且有选择性的ACHE抑制 (IC50 = 1.56μM).
化合物10a和10d显示出显著的抗氧化活性 (IC50 ≈ 8.01 8.52 μg/mL).
化合物10a对Caco-2细胞表现出显著的细胞毒性 (IC50 = 1.77 μM).
分子对接揭示了与胆化酶的化合物10e和10h具有有利的结合能.

结论:

合成的二-二醇混合物具有显著的生物活性.
化合物10e是ACHE抑制的有希望的候选物.
化合物10a显示出作为抗癌和抗氧化剂的潜力.
计算研究支持这些混合物的有利药物相似性和结合相互作用.

关键词:

尼托醇是一种酸.这就是为什么SAR SAR SAR.它具有抗癌活性,具有抗癌活性.抗氧化剂活性抗氧化剂活性胆化酶抑制的抑制作用在的中.三醇三醇的使用方法

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...